NCT00790114View on ClinicalTrials.gov

Determine the Effect of Multiple Doses of AZD7325, CYP Study

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions

Healthy Volunteer

Interventions

DRUG

AZD7325

Oral, day 1-12

DRUG

Midazolam

single dose, twice during treatment

DRUG

Caffeine

single dose, twice during treatment

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY